1. Home
  2. NUTX vs ARVN Comparison

NUTX vs ARVN Comparison

Compare NUTX & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nutex Health Inc.

NUTX

Nutex Health Inc.

HOLD

Current Price

$94.33

Market Cap

655.4M

Sector

Technology

ML Signal

HOLD

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$11.03

Market Cap

781.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUTX
ARVN
Founded
2011
2015
Country
United States
United States
Employees
944
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
655.4M
781.0M
IPO Year
2009
2018

Fundamental Metrics

Financial Performance
Metric
NUTX
ARVN
Price
$94.33
$11.03
Analyst Decision
Strong Buy
Buy
Analyst Count
2
20
Target Price
$252.50
$15.35
AVG Volume (30 Days)
163.2K
770.9K
Earning Date
03-05-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
7.93
58.84
EPS
10.48
N/A
Revenue
$875,257,000.00
$262,600,000.00
Revenue This Year
$8.28
N/A
Revenue Next Year
$1.96
N/A
P/E Ratio
$9.01
N/A
Revenue Growth
82.36
N/A
52 Week Low
$45.88
$5.90
52 Week High
$193.07
$14.22

Technical Indicators

Market Signals
Indicator
NUTX
ARVN
Relative Strength Index (RSI) 40.03 33.97
Support Level $81.70 $11.07
Resistance Level $110.29 $14.03
Average True Range (ATR) 6.97 0.67
MACD 1.07 -0.28
Stochastic Oscillator 29.55 10.66

Price Performance

Historical Comparison
NUTX
ARVN

About NUTX Nutex Health Inc.

Nutex Health Inc is a physician-led, healthcare services and operations company with various hospital facilities in the U.S. states (hospital division), and a primary care-centric, risk-bearing population health management division. The company has three segments: the hospital division, the PHM division, and the real estate division. The hospital division implements and operates health care models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management (PHM) division owns and operates provider networks such as independent physician associations (IPAs). The Real Estate Entities own the land and hospital buildings which are leased to its hospital entities. The majority of the revenue is derived from the Hospital division.

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

Share on Social Networks: